Clinical trial
Prospective Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine
NCT02819115 is registered in ClinicalTrials.gov with Butantan Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine
- Lead sponsor
- Butantan Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- July 31, 2013
- Enrollment
- 63 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
influenza